Pfizer: Intraabdominal Infections trials

The registry lists 19 Intraabdominal Infections studies with Pfizer as lead sponsor. 0 are open to participants now and 15 have results posted.

Phase 1 1Phase 2 4Phase 3 5Phase 4 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal InfectionCompletedNCT04927312Phase 3Results posted
• Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese AdultsCompletedNCT04882085Phase 4Results posted
• Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)CompletedNCT02655419Phase 2Results posted
• Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).CompletedNCT02475733Phase 2Results posted
• Tygacil Drug Use InvestigationCompletedNCT01789905Results posted
• Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd InfectionsCompletedNCT01726023Phase 3Results posted
• A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal InfectionCompletedNCT01721408Phase 4Results posted
• Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant PathogensCompletedNCT01644643Phase 3Results posted
• Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal InfectionsCompletedNCT01499290Phase 3Results posted
• A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal InfectionCompletedNCT01473836Phase 3Results posted
• Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal InfectionsCompletedNCT00929643Results posted
• Post-Authorization Study Evaluating Safety Of TigecyclineCompletedNCT00827541Results posted
• Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal InfectionsCompletedNCT00752219Phase 2Results posted
• Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of AgeCompletedNCT00488345Phase 2Results posted
• Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)CompletedNCT00230971Phase 4Results posted
• Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAPCompletedNCT02364284
• A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and SeparatelyCompletedNCT01430910Phase 1
• Study Evaluating the Etiology of Intra-Abdominal InfectionsCompletedNCT00244088
• Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal InfectionCompletedNCT00044928Phase 4